Cargando…
The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature
INTRODUCTION: Kluyvera ascorbata is a gram-negative, catalase-positive, oxidase-negative, aerobic fermentative bacterium with flagella. This organism colonizes in the human body and its pathogenicity is extremely low; few clinical cases of K. ascorbata infection have been reported. PRESENTATION OF C...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365812/ https://www.ncbi.nlm.nih.gov/pubmed/30775241 http://dx.doi.org/10.1016/j.idcr.2019.e00498 |
_version_ | 1783393491875790848 |
---|---|
author | Mutoh, Yoshikazu Kobe, Tomohisa Hirano, Tomoya Ichihara, Toshihiko Takenaka, Hiroyuki Niinomi, Takuro Umemura, Takumi Kuroiwa, Masanori |
author_facet | Mutoh, Yoshikazu Kobe, Tomohisa Hirano, Tomoya Ichihara, Toshihiko Takenaka, Hiroyuki Niinomi, Takuro Umemura, Takumi Kuroiwa, Masanori |
author_sort | Mutoh, Yoshikazu |
collection | PubMed |
description | INTRODUCTION: Kluyvera ascorbata is a gram-negative, catalase-positive, oxidase-negative, aerobic fermentative bacterium with flagella. This organism colonizes in the human body and its pathogenicity is extremely low; few clinical cases of K. ascorbata infection have been reported. PRESENTATION OF CASE: We report on a patient who experienced severe sepsis and acute cholangitis due to K. ascorbata bacteremia and was treated with levofloxacin following antibiotic susceptibility testing. To our knowledge, this is the first case report of third-generation cephalosporins resistant K. ascorbata infection in Japan. DISCUSSION: Although this pathogen produces innate CTX-M type β-lactamases and is generally resistant to first- and second-generation penicillins and cephalosporins, multi-drug resistant K. ascorbata infection, including ceftriaxone resistant infection has seldom been reported. CONCLUSION: The increase of drug-resistant pathogens is of concern; in such cases, rapid microbial identification and appropriate antibiotic selection are crucial for successful treatment. |
format | Online Article Text |
id | pubmed-6365812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-63658122019-02-15 The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature Mutoh, Yoshikazu Kobe, Tomohisa Hirano, Tomoya Ichihara, Toshihiko Takenaka, Hiroyuki Niinomi, Takuro Umemura, Takumi Kuroiwa, Masanori IDCases Article INTRODUCTION: Kluyvera ascorbata is a gram-negative, catalase-positive, oxidase-negative, aerobic fermentative bacterium with flagella. This organism colonizes in the human body and its pathogenicity is extremely low; few clinical cases of K. ascorbata infection have been reported. PRESENTATION OF CASE: We report on a patient who experienced severe sepsis and acute cholangitis due to K. ascorbata bacteremia and was treated with levofloxacin following antibiotic susceptibility testing. To our knowledge, this is the first case report of third-generation cephalosporins resistant K. ascorbata infection in Japan. DISCUSSION: Although this pathogen produces innate CTX-M type β-lactamases and is generally resistant to first- and second-generation penicillins and cephalosporins, multi-drug resistant K. ascorbata infection, including ceftriaxone resistant infection has seldom been reported. CONCLUSION: The increase of drug-resistant pathogens is of concern; in such cases, rapid microbial identification and appropriate antibiotic selection are crucial for successful treatment. Elsevier 2019-01-29 /pmc/articles/PMC6365812/ /pubmed/30775241 http://dx.doi.org/10.1016/j.idcr.2019.e00498 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Mutoh, Yoshikazu Kobe, Tomohisa Hirano, Tomoya Ichihara, Toshihiko Takenaka, Hiroyuki Niinomi, Takuro Umemura, Takumi Kuroiwa, Masanori The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature |
title | The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature |
title_full | The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature |
title_fullStr | The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature |
title_full_unstemmed | The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature |
title_short | The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature |
title_sort | first case of third-generation cephalosporins resistant kluyvera ascorbata biliary tract infection in japan: a case report and review of the literature |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365812/ https://www.ncbi.nlm.nih.gov/pubmed/30775241 http://dx.doi.org/10.1016/j.idcr.2019.e00498 |
work_keys_str_mv | AT mutohyoshikazu thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT kobetomohisa thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT hiranotomoya thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT ichiharatoshihiko thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT takenakahiroyuki thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT niinomitakuro thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT umemuratakumi thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT kuroiwamasanori thefirstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT mutohyoshikazu firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT kobetomohisa firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT hiranotomoya firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT ichiharatoshihiko firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT takenakahiroyuki firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT niinomitakuro firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT umemuratakumi firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature AT kuroiwamasanori firstcaseofthirdgenerationcephalosporinsresistantkluyveraascorbatabiliarytractinfectioninjapanacasereportandreviewoftheliterature |